NT

N Trupti Raj

Active Director Director DIN 11223269
DIN 11223269 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About N Trupti Raj

Data last updated:

N Trupti Raj is a Director at Crestfield Realty Private Limited (since 2025) and Director at Nexthera Lifecure Private Limited (since 2025). The companies operate in Pharma.

DIN 11223269
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crestfield Realty Private Limited U68100OD2025PTC050670
Director11 Sep 20252025Active
Nexthera Lifecure Private Limited U46497OD2025PTC050059
Director01 Aug 20252025Active

Board colleagues of N Trupti Raj

Directorship timeline

Open interactive timeline →
Crestfield Realty Private Limited
Nexthera Lifecure Private Limited
Premium access

Shareholding and investment profile for N Trupti Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about N Trupti Raj

N Trupti Raj currently holds 2 directorships: Crestfield Realty Private Limited (Director, since 11 Sep 2025); Nexthera Lifecure Private Limited (Director, since 01 Aug 2025).

N Trupti Raj was first appointed on 01 Aug 2025 as Director at Nexthera Lifecure Private Limited.

The current boards of N Trupti Raj's companies include Debidutta Mishra (Crestfield Realty Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available